Rinvoq:
www.medpagetoday.com
A new class of drugs for Crohn's and thus new treatment options. Due to increased risk of blood clots and cancer, use of Rinvoq is to restricted those Crohn's patients who have already flunked therapy with anti-TNFs such as Remicade or Humira.
First JAK Inhibitor Approved for Crohn's Disease
Upadacitinib lands indication for moderately to severely active disease in adults
www.medpagetoday.com
A new class of drugs for Crohn's and thus new treatment options. Due to increased risk of blood clots and cancer, use of Rinvoq is to restricted those Crohn's patients who have already flunked therapy with anti-TNFs such as Remicade or Humira.
Last edited: